Who We Fund
Since 1949, LLS has provided more than $1.8 billion to the best and the brightest blood cancer researchers and biotech companies to support their groundbreaking research. Meet grantees and the companies who’ve joined our fight to find cures and help blood cancer patients everywhere.
Jaehyuk Choi
T-cell lymphoma
Robert Soiffer
transplantation
Craig Jordan
AML
BioInvent International
immunotherapy, indolent NHL, CTCL
Piers Patten
COVID-19
Suzanne Lentzsch
Myeloma
Ivan Odak
Non-Hodgkin's Lymphoma immunotherapy
Carl June
CAR T immunotherapy
Jeremy Baeten
AML
Coleman Lindsley
AML/MDS
Daniel Pollyea
AML
Patrizia Mondello
IgM MGUS & Waldenstrom Macroglobulinemia
Jessica Stewart
Epstein-barr virus and lymphomas
Elliot Stieglitz
CMML
Frederick Locke
lymphoma and immunotherapy
Stephen Gottschalk
pediatric leukemia and CAR-T
Pooja Khandelwal
bone marrow transplantation
Bing Carter
p53 mutant AML
Britta Will
Leukemia and pre-leukemia
Mendel Goldfinger
MDS/AML trials for the elderly
Catriona Jamieson
cancer stem cell biology
Grzegorz Nowakowski
Clinical trial access
Helen Parsons
Equity in Access
Nitin Jain
CLL
Sam Butterworth
CMML
Soheil Meshinchi
pediatric AML
Jean Koff
Disparities in DLBCL
Andrew Lane
BPDCN
Jayna Mistry
aging and leukemias
Auron Therapeutics
degrader, AML, MDS
Reina Takeda
AML
Adam de Smith
pediatric ALL and Down Syndrome
Jeetayu Biswas
splicing in myeloid diseases
Caner Saygin
T-ALL
Nizar Bahlis
Myeloma immunotherapy
Thomas Kipps
Hairy Cell Leukemia
Ari Melnick
epigenetics and lymphoma
Todd Fehniger
NK/CART cell therapy for lymphomas and pediatric AML
Philippe Armand
follicular lymphoma
Caron Jacobson
lymphoma and immunotherapy
Courtney Jones
AML metabolism
Lei Ding
myeloproliferative neoplasms, myelofibrosis
Daniel Thomas
Myelofibrosis
Catherine Smith
leukemia
Armin Rashidi
gut bacteria and transplant success
Paola Aguilar Neuville
Primary cutaneous γδ T-cell lymphoma
Marina Konopleva
MDS/AML metabolism
Michaela Reagan
Multiple Myeloma
Paolo Strati
Non-Hodgkin Lymphoma
F. Lennie Wong
Equity in Access
Bailee Kain
AML and African ancestry
Jun Qi
Myeloma
Faron Pharmaceuticals
immunotherapy, MDS
Srividya Swaminathan
pediatric, immunotherapy
Grant Challen
preleukemia, leukemia
Wendy Béguelin
follicular lymphoma
Enterome
vaccine, FL, MZL
Jake Shortt
precision therapy for aggressive lymphomas
Jane Oliaro
Myeloma & Lymphoma Immunotherapy
Xu Ji
Equity in Access
Julia Maxson
AML
Saar Gill
AML immunotherapy
Vittoria Biotherapeutics
immunotherapy, CAR-T, TCL
Timothy Graubert
AML and MDS biology
Yiman Liu
Epigenetics and leukemia
Solu Therapeutics
immunotherapy, CMML
Justine Kahn
pediatric leukemia and lymphoma
Teresa Palomero
Peripheral T-cell Lymphoma
Daphne Friedman
Equity in Access
Qing Yi
Novel CAR-T
Lev Kats
myeloma and epigenetics
James Rubenstein
Lymphoma of the Central Nervous System
Matthew Frank
Lymphoma CART therapy
Marc Seifert
Hairy cell leukemia
Mark Murakami
follicular lymphoma
Julia Paczkowska
immunobiology of Hodgkin's disease
Koichi Takahashi
AML/MDS
Shazia Nakhoda
Equity in Access
Ryvu Therapeutics
AML, MDS, Myelofibrosis
Constellation Pharmaceuticals
myeloproliferative neoplasms
Enrico Tiacci
Hairy cell leukemia
Leandro Cerchietti
DLBCL
Inhye Ahn
CLL
Alfred Garfall
myeloma immunotherapy
Hong Wen
AML
Sheng Li
Aging and AML
Eric Padron
CMML
Caribou Biosciences
immunotherapy, allo-CAR, NHL, MM
Christian Steidl
B-cell lymphomas
Nicola Vannini
Aging and CAR-T success
Christopher Porter
Leukemia, lymphoma
Dimericon Therapeutics
dimericons, blood cancer
Courtney DiNardo
clinical trials, AML
Alex Kentsis
pediatric leukemias
Michael Savona
MDS and leukemia
Omar Abdel-Wahab
Hairy cell leukemia
John Leonard
lymphoma research
Dren Bio
immunotherapy, cytotoxic lymphomas, LGLL
Ricky Johnstone
lymphoma and myeloma
Kerry Rogers
CLL
Gaurav Goyal
Erdheim-Chester Disease
Steven Park
follicular lymphoma
Jolanta Grembecka
leukemia therapeutics
Constantine Mitsiades
CAR-T and CAR-NK immunotherapies
Markus Muschen
leukemia and lymphoma biology
Anouchka Laurent
T-cell lymphoma
Rajni Kumari
AML
Sigurður Kristinsson
Smoldering myeloma
Rgenta Therapeutics
RNA-targeting, blood cancer
Dane Vassiliadis
blood cancer biology
Sriram Sundaravel
AML stem cells
Eric Pietras
AML
Pietro Genovese
transplant and AML
Jonathan Licht
DNA biology, myeloma
Roberta Zappasodi
lymphoma, immunotherapy
Jing Fu
myeloma
Sergei Doulatov
Leukemias
John Crispino
myelofibrosis, pediatric leukemia and Downs
Jianhua Yu
myeloma immunotherapy
Margaret Shipp
lymphoma biology
Mark Dawson
B-ALL and CAR-T resistance
Fahmin Basher
transplant and GvHD
Adi Nagler
Bronchiolitis obliterans after transplant
Riccardo Dalla-Favera
lymphoma (DLBCL)
Michael Wang
Mantle Cell Lymphoma
Hao Jiang
DNA biology and leukemia
Shannon Maude
Immunotherapy for ALL
George Daley
"off-the-shelf" CAR-T and CAR-NK
Matteo Bellone
Smoldering multiple myeloma
Ravi Bhatia
transplantation
Daniel Lucas
bone marrow and leukemia biology
Brian Walker
smoldering myeloma, MGUS
Adam Olszewski
Follicular and marginal zone lymphoma
Trent Hall
MDS
Lucy Godley
preleukemia
Jalpa Doshi
Equity in Access
Bruno Paiva
smoldering myeloma
Liran Shlush
pre-leukemia
Thomas LeBlanc
palliative care
Kathleen Sakamoto
pediatric AML
Taishi Yonezawa
AML
Paul Beavis
immunotherapy in myeloma
Fenghuang Zhan
Myeloma and bone disease
Michael Green
lymphoma biology
Mala Shanmugam
myeloma
Brian Dalton
DNA mutations and myeloid cancers
Venkata Lokesh Battula
immunotherapy and AML
Alieen Rowan
Adult T cell leukemia/lymphoma
Affimed
immunotherapy, HL, PTCL
Marco Ruella
Immunotherapy for T-cell lymphoma
Peter Klein
MDS
Suman Paul
T cell cancers and immunotherapy
Simona Colla
Myeloma biology
Caroline Arber
myeloma CAR-T
Steven Treon
Lymphomas and Waldenstrom's
Yibin Yang
Lymphoma
Christopher Booth
BPDCN
Ann-Kathrin Eisfeld
Racial diversity in AML
Tycel Phillips
Mantle Cell Lymphoma
Oreofe Odejide
Equity in Access
Christopher Flowers
clinical trial access
Maximilian Stahl
AML immunotherapy
Thomas Koehnke
leukemia
Michael Keller
COVID-19, immunotherapy
Rayne Rouce
Immunotherapy for pediatric, adolescent & young adult patients
Ana Vujovic
AML
Amit Verma
AML/MDS
Jennifer Woyach
CLL trials
Kirk Schultz
pediatric transplantation
Yan Liu
MDS
Catherine Bollard
pediatric blood cancers and immunotherapy
Robert Orlowski
(Smoldering) Multiple Myeloma
Sham Mailankody
Myeloma immunotherapy clinical trials
Noemí Puig Morón
Myeloma
Catherine Diefenbach
DLBCL immunology
Christian Marinaccio
MLL leukemias
Tak Mak
Immunotherapy
Madhav Dhodapkar
multiple myeloma immunotherapy
Nicolas Nassar
pediatric leukemia
Peter Croucher
Multiple Myeloma
Jenny Wang
AML
Urvi Shah
Diet and myeloma
George Vassiliou
Leukemia Prevention
Jeffrey Magee
pediatric AML
Cailin Collins
Leukemia and pre-leukemia
Lindsey Montefiori
pediatric leukemia
Daisuke Nakada
preleukemia, leukemia
Mark Hamilton
DLBCL and CAR-T
Ravindra Majeti
preleukemia, AML
Liling Wan
AML
Megan McNerney
AML/MDS
Huda Salman
CMML
Siddhartha Jaiswal
preleukemia
Jennifer Amengual
lymphomas after transplant
Takeshi Sugio
T-cell lymphoma
William Matsui
Myeloma
Yoke Seng Lee
AML
Rizwan Romee
Immunotherapy
Kura Oncology
MLL leukemia, AML
Stacie Dusetzina
Equity in Access
Roland Walter
Antibody-based AML therapies
Nirav Shah
CAR-T for lymphoma
Tomasz Skorski
myeloproliferative neoplasms, AML
Lori Muffly
Equity in Access
Paolo Caimi
CAR-T clinical trial for CLL
Anthony Letai
improving CAR-T
Gianpietro Dotti
CAR T and AML
Steven Horwitz
T-cell lymphomas
H. Irene Su
Equity in Access
Andrew Hantel
Equity in Access
Immune-Onc Therapeutics
immunotherapy, AML, CMML
Zachary Epstein-Peterson
Peripheral T-cell lymphoma trial
Neha Mehta-Shah
T-cell lymphoma
Michael Kharas
leukemia
Stephen Nimer
myeloid cancer biology
Carma Bylund
Equity in Access
Ruben Carrasco
Myeloma
Keisuke Ito
blood cancer stem cells and MDS metabolism
Richard Lock
T-ALL
Anushree Vichare
Equity in Access
Kimberly Stegmaier
childhood blood cancers
Siegfried Janz
Myeloma immunotherapy
Joachim Yahalom
Lymphoma
Jianguo Tao
Mantle Cell Lymphoma
Manyi Wei
acute megakaryoblastic leukemia
Ramon Massoni-Badosa
CLL and Richter's Syndrome
Logan Spector
childhood leukemia epidimiology
Immunitas Therapeutics
immunotherapy, DLBCL, Hodgkin's
Kasey Leger
pediatric blood cancers
Qingyu Luo
BPDCN
Meng Li
Equity in Access
Wendy Stock
T-cell ALL
Jennifer Trowbridge
aging and leukemia
Eugenio Morelli
Myeloma
Luca Busino
DLBCL
ImCheck Therapeutics
immunotherapy, AML
Tanya Siddiqi
clinical trial access
Jonas Jutzi
myeloproliferative neoplasms
Lawrence Boise
CART and myeloma
Ronald Levy
immunotherapies, COVID-19
Dan Landau
cancer evolution biology
Christine Zhang
AML
Martin Dreyling
Mantle Cell Lymphoma
Carl Allen
pediatric blood cancers
Jing Yang
Myeloma
Anita Kumar
Mantle Cell Lymphoma immunotherapy
Nataly Cruz-Rodriguez
T-ALL and metabolism
Yubin Zhou
peripheral T cell lymphoma
Daniel Herranz
T-ALL
Tyler Parsons
MPN and AML
Raymond Mailhot
Equity in Access
Sahand Hormoz
MPN
Jonathon Cohen
lymphoma clinical trial access in Georgia
Alexey Danilov
lymphoma
Sarah Tasian
pediatric leukemias
Rong Lu
preleukemia, leukemia
Eirini Papapetrou
blood cancer stem cells
Randall Davis
CLL
Bingyi Chen
AML immunotherapy
Rachel Mersfelder
AMKL
John DiPersio
trispecific antibody for AML and MDS
Nicoletta Cieri
AML and transplantation